Evidence map›Paper›PMID 36751856›Full record

Observational studyGut microbes

Gluten-free diet affects fecal small non-coding RNA profiles and microbiome composition in celiac disease supporting a host-gut microbiota crosstalk.

Antonio Francavilla, Giulio Ferrero, Barbara Pardini, Sonia Tarallo, Laura Zanatto, Gian Paolo Caviglia, Sabina Sieri, Sara Grioni, Giulia Francescato, Francesco Stalla and 8 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Circulating MicroRNAs and Cytokines Associated with Celiac Disease.Middle East journal of digestive diseases · 2024
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 3 countries.

Antonio FrancavillaMolecular and Genetic Epidemiology, Italian Institute for Genomic Medicine (IIGM), Torino, Italy.ORCID 0000-0003-1594-2837
Giulio FerreroDepartment of Computer Sciences, University of Torino, Torino, Italy.ORCID 0000-0002-4580-0680
Barbara PardiniMolecular and Genetic Epidemiology, Italian Institute for Genomic Medicine (IIGM), Torino, Italy.ORCID 0000-0001-9571-4257
Sonia TaralloMolecular and Genetic Epidemiology, Italian Institute for Genomic Medicine (IIGM), Torino, Italy.ORCID 0000-0003-0887-2607
Laura ZanattoMolecular and Genetic Epidemiology, Italian Institute for Genomic Medicine (IIGM), Torino, Italy.
Gian Paolo CavigliaDivision of Gastroenterology, Department of Medical Sciences, University of Torino, Torino, Italy.ORCID 0000-0002-0529-9481
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.ORCID 0000-0001-5201-172X
Sara GrioniEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milano, Italy.
Giulia FrancescatoMolecular and Genetic Epidemiology, Italian Institute for Genomic Medicine (IIGM), Torino, Italy.ORCID 0000-0002-4501-4209
Francesco StallaGastroenterology and Digestive Endoscopy Unit, "Città della Salute e della Scienza" Hospital, Torino, Italy.
Cristina GuiottoGastroenterology, Hospital Mauriziano Umberto I, Torino, Italy.
Lucia CrocellaGastroenterology, Hospital Mauriziano Umberto I, Torino, Italy.
Marco AstegianoGastroenterology and Digestive Endoscopy Unit, "Città della Salute e della Scienza" Hospital, Torino, Italy.
Mauro BrunoGastroenterology and Digestive Endoscopy Unit, "Città della Salute e della Scienza" Hospital, Torino, Italy.
Pier Luigi CalvoPediatric Gastroenterology Unit, Department of Pediatrics, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di, Torino, Italy.
Paolo VineisSchool of Public Health, Imperial College London, London, UK.ORCID 0000-0001-8935-4566
Davide Giuseppe RibaldoneDivision of Gastroenterology, Department of Medical Sciences, University of Torino, Torino, Italy.ORCID 0000-0002-9421-3087
Alessio NaccaratiMolecular and Genetic Epidemiology, Italian Institute for Genomic Medicine (IIGM), Torino, Italy.ORCID 0000-0001-5774-0905
Italian institute for Genomic Medicine · ITAzienda Ospedaliera Citta' della Salute e della Scienza di Torino · ITUniversity of Turin · ITFondazione IRCCS Istituto Nazionale dei Tumori · ITImperial College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Current treatment for celiac disease (CD) is adhering to a gluten-free diet (GFD), although its long-term molecular effects are still undescribed. New molecular features detectable in stool may improve and facilitate noninvasive clinical management of CD. For this purpose, fecal small non-coding RNAs (sncRNAs) and gut microbiome profiles were concomitantly explored in CD subjects in relation to strict (or not) GFD adherence over time. In this observational study, we performed small RNA and shotgun metagenomic sequencing in stool from 63 treated CD (tCD) and 3 untreated subjects as well as 66 sex- and age-matched healthy controls. tCD included 51 individuals on strict GFD and with negative transglutaminase (TG) serology (tCD-TG-) and 12 symptomatic with not strict/short-time of GFD adherence and positive TG serology (tCD-TG+). Samples from additional 40 healthy adult individuals and a cohort of 19 untreated pediatric CD subjects and 19 sex/age matched controls were analyzed to further test the outcomes. Several miRNA and microbial profiles were altered in tCD subjects (adj. p < .05). Findings were validated in the external group of adult controls. In tCD-TG-, GFD duration correlated with five miRNA levels (p < .05): for miR-4533-3p and miR-2681-3p, the longer the diet adherence, the less the expression differed from controls. tCD-TG+ and untreated pediatric CD patients showed a similar miRNA dysregulation. Immune-response, trans-membrane transport and cell death pathways were enriched in targets of identified miRNAs.

Indexed as

Celiac DiseaseGastrointestinal MicrobiomeMicroRNAsAdultChildDiet, Gluten-FreeGlutensHumansGlutensMicroRNAsceliac diseasegluten-free dietgut microbiotaStool microRNAs

Identifiers

PMID36751856
PMCPMC9928459
OpenAlexW4319461584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.